Paper326604
C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
Faber OK and 1 other. Diabetes, 1977. Cited by 475 papers, by iCite.
Cite this record
ConductScience Library. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Papers, record 326604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| C-Peptide | Major topic |
| Diabetes Mellitus | Major topic |
| Glucagon | Major topic |
| Islets of Langerhans | Major topic |
| Peptides | Major topic |
| Adolescent | |
| Adult | |
| Blood Glucose | |
| Child | |
| Fasting | |
| Female | |
| Humans | |
| Insulin | |
| Male | |
| Middle Aged |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01480843 | Simplified Insulin Protocol Using Lantus in Elderly | Background |
Source ClinicalTrials.gov
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 475 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41376852 | Effect of Beta-Cell Function on Glucose Variability When Switching From Insulin Degludec Plus a Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide: Preliminary Results From a Pilot Study. | Int J Endocrinol | 2025 | https://conductscience.org/library/papers/41376852 | PubMed |
| 41214251 | Clinical, immunogenetic and metabolic characteristics of autoantibody-negative and autoantibody-positive type 1 diabetes. | Diabetologia | 2026 | https://conductscience.org/library/papers/41214251 | PubMed |
| 39656436 | Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. | J Endocrinol Invest | 2025 | https://conductscience.org/library/papers/39656436 | PubMed |
| 38015721 | High Doses of Exogenous Glucagon Stimulate Insulin Secretion and Reduce Insulin Clearance in Healthy Humans. | Diabetes | 2024 | https://conductscience.org/library/papers/38015721 | PubMed |
| 36184780 | Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy). | Diabetes Obes Metab | 2023 | https://conductscience.org/library/papers/36184780 | PubMed |
| 35574023 | Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35574023 | PubMed |
| 34610719 | Assessment of Insulin Secretion and Insulin Resistance in Human. | Diabetes Metab J | 2021 | https://conductscience.org/library/papers/34610719 | PubMed |
| 34510360 | Circulating Hematopoietic (HSC) and Very-Small Embryonic like (VSEL) Stem Cells in Newly Diagnosed Childhood Diabetes type 1 - Novel Parameters of Beta Cell Destruction/Regeneration Balance and Possible Prognostic Factors of Future Disease Course. | Stem Cell Rev Rep | 2022 | https://conductscience.org/library/papers/34510360 | PubMed |
| 32775460 | Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes. | J Diabetes Res | 2020 | https://conductscience.org/library/papers/32775460 | PubMed |
| 31745069 | Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3. | Am J Case Rep | 2019 | https://conductscience.org/library/papers/31745069 | PubMed |
| 30853818 | A case of nivolumab-induced acute-onset type 1 diabetes mellitus in melanoma. | Curr Oncol | 2019 | https://conductscience.org/library/papers/30853818 | PubMed |
| 30788807 | C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study. | Diabetes Ther | 2019 | https://conductscience.org/library/papers/30788807 | PubMed |
| 30392045 | Capturing residual beta cell function in type 1 diabetes. | Diabetologia | 2019 | https://conductscience.org/library/papers/30392045 | PubMed |
| 28494143 | Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity. | J Diabetes Investig | 2018 | https://conductscience.org/library/papers/28494143 | PubMed |
| 28484968 | A Practical Review of C-Peptide Testing in Diabetes. | Diabetes Ther | 2017 | https://conductscience.org/library/papers/28484968 | PubMed |
| 26849676 | C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus. | PLoS One | 2016 | https://conductscience.org/library/papers/26849676 | PubMed |
| 26607818 | Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus. | Med Biol Eng Comput | 2015 | https://conductscience.org/library/papers/26607818 | PubMed |
| 24843713 | Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function. | J Diabetes Investig | 2013 | https://conductscience.org/library/papers/24843713 | PubMed |
| 24843526 | Analysis of factors influencing postprandial C-peptide levels in Japanese patients with type 2 diabetes: Comparison with C-peptide levels after glucagon load. | J Diabetes Investig | 2011 | https://conductscience.org/library/papers/24843526 | PubMed |
| 24843502 | Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes. | J Diabetes Investig | 2011 | https://conductscience.org/library/papers/24843502 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326604
GET https://conductscience.org/api/papers/v1/326604/cited_by?page=2